FDA Drugs (New Approvals & NDA)Original article
FDA warns about serious problems with high doses of the allergy medicine diphenhydramine (Benadryl)
RegulatoryBenadrylNegative
AI Analysis
Summary
The FDA issued a safety warning regarding serious problems associated with high doses of diphenhydramine (Benadryl), an over-the-counter allergy medication. The warning was communicated through an FDA Drug Safety Communication podcast.
Outcome Details
FDA safety warning regarding serious problems associated with high doses
Importance:6/10
Sentiment:
-0.70
safety warningdiphenhydraminehigh dose risksover-the-counterdrug safety
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on April 7, 2026 4:47 PM